| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/01/1993 | EP0557448A1 Preparation of nucleic acid samples |
| 09/01/1993 | EP0557442A1 Antithrombosis agents |
| 09/01/1993 | EP0557418A1 A $g(b)-TYPE TRANSFORMING GROWTH FACTOR |
| 09/01/1993 | EP0557388A1 Diagnosis and treatment of multiple sclerosis |
| 09/01/1993 | EP0557300A1 Bispecific antibodies, method of production, and uses thereof |
| 09/01/1993 | EP0527954A4 Molecular recognition units |
| 08/31/1993 | US5241052 Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses |
| 08/31/1993 | US5241047 Synthetic peptides and mixtures thereof for detecting HIV antibodies |
| 08/31/1993 | US5240912 Transforming growth factor (TGF) peptides |
| 08/31/1993 | US5240864 Method of assaying or analyzing subtypes of human leukocyte interferons or their antibodies, and antibodies to be used therefor |
| 08/31/1993 | US5240848 Cloning; genetic engineering |
| 08/31/1993 | US5240846 Gene therapy vector for cystic fibrosis |
| 08/31/1993 | US5240843 Enzyme stabilisation |
| 08/31/1993 | US5240833 Method for the production of monoclonal antibodies directed to tumor-associated gangliosides and fucogangliosides |
| 08/31/1993 | US5240705 Haemophilus paragallinarum vaccine |
| 08/31/1993 | US5240704 Vaccine, antibodies & antibody-containing compositions for inhibiting human dental caries induced by streptococcus mutans |
| 08/31/1993 | CA1321765C Immunodiagnostic assays using chimeric antigens |
| 08/31/1993 | CA1321763C Monoclonal antibody specific to human pancreatic phospholipase a |
| 08/30/1993 | CA2090530A1 Complexes containing glycosyl-phosphatidylinositol proteins and cholanic acid derivatives, a process for their preparation and their use |
| 08/29/1993 | CA2089966A1 Antigen binding proteins and methods for their production |
| 08/25/1993 | EP0556726A1 Process for stabilisation of proteins |
| 08/25/1993 | EP0556496A2 Antibodies against tumor-associated mucin glycoprotein |
| 08/25/1993 | EP0556344A1 New insulin-like growth factor binding protein (igfbp-6) |
| 08/25/1993 | EP0556327A1 Method for determining the sensitivity and/or specificity of an assay system for detecting antibodies |
| 08/25/1993 | EP0556320A1 Monoclonal antibodies to hepatitis c virus and method for using same |
| 08/25/1993 | EP0556292A1 Hepatitis c virus asialoglycoproteins |
| 08/25/1993 | EP0556272A1 Therapeutic and diagnostic methods using total leukocyte surface antigens |
| 08/25/1993 | EP0199801B1 Methods for protein binding enzyme complementation assays |
| 08/24/1993 | US5239086 Haptens and tracers for immunoassays for propoxyphene |
| 08/24/1993 | US5239060 Muscular dystrophy protein, dystrophin |
| 08/24/1993 | US5239056 Peptide fractions which induce antibodies protecting against the bovine leukemia virus, a process for obtaining such fractions, their coding sequences and vaccines made from such fractions |
| 08/24/1993 | US5238963 Treatment with compound to prevent crosslinking of glycosylation products |
| 08/24/1993 | US5238916 Stimulates proliferation of mesodermal cells and growth of capillaries, promotes tissue repair |
| 08/24/1993 | US5238839 Nucleic Acids Encoding proteins which induce immunological effector cell activation and chemattraction, vectors, and recombinant cells |
| 08/24/1993 | US5238836 Genetic engineering; isolated DNA sequences |
| 08/24/1993 | US5238824 Hybridomas and monoclonal antibodies therefrom reactive toward antigens from edwardsiella ictaluri |
| 08/24/1993 | US5238820 Multiply-amplifiable vectors for high level expression of exogenuos DNA |
| 08/24/1993 | CA1321582C Disulfur analogs of ll-e33288 antitumor agents |
| 08/19/1993 | WO1993016388A1 Method of detecting and monitoring levels of 3'-amino-3'-deoxythymidine in body fluids and antibodies for same |
| 08/19/1993 | WO1993016193A1 Cell adhesion inhibiting antibody and cell adhesion inhibitor containing the same |
| 08/19/1993 | WO1993016192A1 Humanised antibody against hepatitis |
| 08/19/1993 | WO1993016185A2 Biosynthetic binding protein for cancer marker |
| 08/19/1993 | WO1993016184A1 Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5 |
| 08/19/1993 | WO1993016183A1 Cyclophilin associated membrane proteins dna sequences |
| 08/19/1993 | WO1993016181A1 A 90k tumor-associated antigen, ir-95 |
| 08/19/1993 | WO1993016102A1 Human cd26 and methods for use |
| 08/19/1993 | WO1993016099A2 Dna sequences encoding novel growth/differentiation factors |
| 08/19/1993 | WO1993016096A1 Recombinant gibberellin dna and uses thereof |
| 08/19/1993 | WO1993015766A1 Desensitization to specific allergens |
| 08/19/1993 | WO1993015764A1 Treatment for inflammatory bowel disease |
| 08/19/1993 | WO1993015747A1 A method of using cd4-containing molecules to substantially reduce the risk of occupational hiv transmission |
| 08/19/1993 | CA2372813A1 Biosynthetic binding protein for cancer marker |
| 08/19/1993 | CA2129517A1 Recombinant gibberellin dna and uses thereof |
| 08/19/1993 | CA2129445A1 Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5 |
| 08/18/1993 | EP0556152A1 Pyridinium derivatives and their use in determining connective tissue disorders in humans and animals |
| 08/18/1993 | EP0556111A1 Hybrid protein complexes, their process of preparation, and their applications as an agent in diagnostic and in the therapeutic field or as a reagent relevant in medical approaches |
| 08/18/1993 | EP0556106A2 Antibody binding to human aldose reductase and its uses |
| 08/18/1993 | EP0555989A1 TGF-beta induced gene and protein |
| 08/18/1993 | EP0555880A2 The CD40CR receptor and ligands therefor |
| 08/18/1993 | EP0555425A1 Antibodies to streptolysin o derivatives and variants |
| 08/18/1993 | EP0555418A1 Peptide binding assays with mhc antigens |
| 08/18/1993 | EP0555397A1 Polypeptide with kd hmfg differentiation antigen binding specificity |
| 08/18/1993 | EP0555291A1 Vaccinia vectors, vaccinia genes and expression products thereof |
| 08/18/1993 | EP0555286A1 Cell growth inhibitors |
| 08/18/1993 | EP0555231A1 REGULATION OF NEOPLASTIC CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR |
| 08/18/1993 | EP0555205A1 Dna encoding a growth factor specific for epithelial cells |
| 08/18/1993 | EP0542897A4 Producing monoclonal antibodies against human t-cell receptor elements using recombinant dna vectors |
| 08/17/1993 | US5237057 Monitoring drug abuse |
| 08/17/1993 | US5237054 Stabilized aqueous composition containing antibodies |
| 08/17/1993 | US5237053 Vaccines containing flagellar antigens |
| 08/17/1993 | US5236836 Catalyst for the hydrolysis of peptide bond in vasoactive intestinal peptide |
| 08/17/1993 | US5236834 Isolating gene for protein; constructing nucleotide corresponding to DNA coding region; medical diagnosis |
| 08/17/1993 | US5236829 Method of producing monokine induced by gamma interferon |
| 08/17/1993 | US5236825 Complexing |
| 08/17/1993 | US5236694 19f labelled dextrans and antibodies as nmr imaging and spectroscopy agents |
| 08/13/1993 | WO1993015759A1 Autoantibody assay and usage in the control of human disease |
| 08/13/1993 | CA2129895A1 Autoantibody assay and usage in the control of human disease |
| 08/12/1993 | CA2089139A1 Complex hybrid proteins, method for preparing them, their applications as diagnostic agent, as agent intended for therapeutic use |
| 08/11/1993 | EP0554708A1 Thioether conjugates |
| 08/11/1993 | EP0554670A2 Specific antibodies against activated platelets, their production and applications in diagnostics and therapeutics |
| 08/11/1993 | EP0554458A1 Immunoassay, monoclonal antibody and hybridoma |
| 08/11/1993 | EP0554446A1 Monoclonal antibodies useful in therapy of HIV-1 infection |
| 08/11/1993 | EP0554441A1 Methods and compositions for cancer therapy and for prognosticating responses to cancer therapy |
| 08/11/1993 | EP0554401A1 Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120 |
| 08/11/1993 | EP0554383A1 Blood coagulation protein antagonists and uses therefor |
| 08/11/1993 | EP0554364A1 Lipid a composition as immunogenic agents to prevent or treat gram-negative bacterial infections |
| 08/11/1993 | EP0554358A1 Chelating agents |
| 08/11/1993 | EP0554356A1 A monoclonal antibody |
| 08/11/1993 | EP0554344A1 Pharmaceutical composition for the treatment or prevention of a malignant tumor |
| 08/11/1993 | EP0307402B1 Production of m-csf |
| 08/11/1993 | EP0194276B1 Production of chimeric antibodies |
| 08/10/1993 | US5235049 Nucleic acid sequences encoding a soluble molecule (SICAM-1) related to but distinct from ICAM-1 |
| 08/10/1993 | US5235042 Purified, angiogenic and releasable from heparin, with which it complexes, by salt elution; cationic, culture product from hepatoma or chondrosarcoma cells |
| 08/10/1993 | US5234991 Capable of fixing thereto biological macromolecules |
| 08/10/1993 | US5234839 Compositions for detecting ras gene proteins and cancer therapeutics |
| 08/10/1993 | US5234822 Diagnosis, therapy, vaccines |
| 08/10/1993 | US5234820 Exopeptidase catalyzed site-specific bonding of supports, labels and bioactive agents to proteins |
| 08/10/1993 | US5234815 Monoclonal antibodies against cytosolic thyroid hormone binding protein |
| 08/10/1993 | US5234685 Method of determining incompatibility-reaction-causing substances in blood products as well as a method of inactivating said incompatibility-reaction-causing substances |
| 08/10/1993 | CA1321143C High titer varicella zoster immune globulin for intravenous administration |